Industria de la salud

Benchmark International is pleased to announce the transaction between Theatre and Endoscopy Service Technicians (T.E.S.T.) and Teqnion.

Benchmark International is verheug om die transaksie tussen Theatre and Endoscopy Service Technicians (T.E.S.T.) en Teqnion aan te kondig.

Benchmark International is pleased to announce the transaction between Triducive and Bioscript.

Benchmark International se complace en anunciar la transacción entre Triducive y Bioscript.

Benchmark International is verheug om die transaksie tussen Triducive en Bioscript aan te kondig.

Benchmark International is delighted to announce the acquisition of Webmed Pharmacy by Vulcan Two.

Benchmark International se complace en anunciar la adquisición de Webmed Pharmacy por Vulcan Two.

Benchmark International is verheug om die verkryging van Webmed Pharmacy deur Vulcan Two aan te kondig.

Benchmark International is pleased to announce the acquisition of biocheck Hygienetechnisches Labor GmbH by viridiusLAB AG.

Benchmark International se complace en anunciar la adquisición de biocheck Hygienetechnisches Labor GmbH por parte de viridiusLAB AG.

The multi-billion-dollar healthcare technology industry continues to thrive at impressive compound annual growth rates (CAGR) year after year. There is an increasing number of investments and initiatives supporting digital health, healthcare IT infrastructure, big data analytics, artificial intelligence (AI), electronic health records (EHR), and several other areas of advancement.

El sector de la tecnología sanitaria, que mueve miles de millones de dólares, sigue creciendo año tras año a un ritmo impresionante. Cada vez hay más inversiones e iniciativas en apoyo de la salud digital, la infraestructura de TI sanitaria, el análisis de macrodatos, la inteligencia artificial (IA), la historia clínica electrónica (HCE) y otras áreas de avance.

The value of the trillion-dollar healthcare services market continues to surge as expenditure on medicine grows significantly year after year. Pharmaceutical companies, long-term care facilities, medical device companies, medical building management, and medical consumables all drive the market forward. As an end-use segment, hospitals hold the most extensive consumer base in the healthcare services industry.

El valor del mercado de servicios sanitarios, que mueve un billón de dólares, sigue aumentando a medida que el gasto en medicina crece significativamente año tras año.Las empresas farmacéuticas, los centros de cuidados de larga duración, las empresas de dispositivos médicos, la gestión de edificios médicos y los consumibles médicos impulsan el mercado. Como segmento de uso final, los hospitales cuentan con la base de consumidores más amplia del sector de servicios sanitarios.

Los sectores de productos sanitarios y suministros médicos siguen mostrando fuertes tasas de crecimiento anual compuesto (TCAC) con valores de mercado de cientos de miles de millones. Se espera que esta tendencia continúe, ya que la población mundial está envejeciendo y las soluciones sanitarias son cada vez más innovadoras.

The healthcare devices and medical supplies sectors continue demonstrating strong compound annual growth rates (CAGR) with hundreds of billions of market values. This trend is expected to continue as global populations are aging and healthcare solutions are becoming more innovative.

In April, we published our 2024 Global Healthcare & Medical Industry Report, which covered the surging value of the healthcare market and the positive expectations regarding M&A activity and deal value for this year. As we move further into the year, we are seeing more positive private equity trends and investment strategies for the healthcare services industry, as dealmaking is now beginning to pick up momentum following a bit of a decline in Q2 of 2024. Investment pipelines are starting to build up at the same time that seller expectations are being tempered.

According to Verified Market Research, the global healthcare market will reach $665.37 billion by 2028. The healthcare sector is primarily segmented into pharmaceuticals, services, devices, and others. By application, the industry is categorized by cardiovascular, oncology, anti-infection, central nervous system, respiratory, and others.

Explore the latest insights and trends shaping the 2024 M&A landscape in our newest article. Discover key strategies and predictions that could redefine business acquisitions this year. Stay informed and ahead of the curve with Benchmark International's comprehensive outlook.

Behavioral healthcare services M&A has been on the rise in recent years due to the high demand for mental and behavioral health services in the US. The behavioral healthcare market saw a 45% increase in 2022 versus the prior year and remains a fast market in early 2023.Outpatient behavioral healthcare services have become increasingly popular due to their accessibility and cost-effectiveness. As more patients seek treatment for mental and behavioral health issues, the demand for outpatient services grows. Investors are particularly interested in outpatient services that offer comprehensive care, including individual and group therapy, medication management, and community-based support services.In addition to private equity firms, strategic buyers such as healthcare systems and payers also show interest in the behavioral healthcare services market. These players want to diversify their revenue streams and expand their offerings to meet the growing mental and behavioral health services demand.Recent federal funding and investments to expand coverage and access to critical services have also increased M&A activity in the behavioral healthcare services sector. In March 2022, the US House of Representatives passed a $1.5 trillion spending package that included financial support programs to expand mental healthcare. The package granted $2.14 billion in funding to the National Institute for Mental Health (NIMH) to bolster research on the impact of the pandemic on mental health, an increase of $37 million from 2021.